Evidence map›Paper›PMID 40382314›Full record

ArticleNature communications2025

Conformational trajectory of the HIV-1 fusion peptide during CD4-induced envelope opening.

Bhishem Thakur, Revansiddha H Katte, Wang Xu, Katarzyna Janowska, Salam Sammour, Rory Henderson, Maolin Lu, Peter D Kwong, Priyamvada Acharya

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Bhishem ThakurDuke Human Vaccine Institute, Duke University, Durham, NC, USA.
Revansiddha H KatteDepartment of Cellular and Molecular Biology, School of Medicine, University of Texas at Tyler Health Science Center, Tyler, Texas, USA.ORCID http://orcid.org/0000-0002-3844-8797
Wang XuDepartment of Cellular and Molecular Biology, School of Medicine, University of Texas at Tyler Health Science Center, Tyler, Texas, USA.ORCID http://orcid.org/0000-0003-4452-9240
Katarzyna JanowskaDuke Human Vaccine Institute, Duke University, Durham, NC, USA.
Salam SammourDuke Human Vaccine Institute, Duke University, Durham, NC, USA.
Rory HendersonDuke Human Vaccine Institute, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0002-4301-6382
Maolin LuDepartment of Cellular and Molecular Biology, School of Medicine, University of Texas at Tyler Health Science Center, Tyler, Texas, USA.
Peter D KwongAaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, and Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0003-3560-232X
Priyamvada AcharyaDuke Human Vaccine Institute, Duke University, Durham, NC, USA. priyamvada.acharya@duke.edu.ORCID http://orcid.org/0000-0002-0089-277X

Funding

Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block reboundU54AI170752 · NIAID · DUKE UNIVERSITY · PI Rory Henderson · 2022 to 2026
$32.0M
Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics developmentR01AI145687 · NIAID · DUKE UNIVERSITY · PI Priyamvada Acharya · 2019 to 2026
$6.9M
The role of conformational dynamics of enveloped virus spike proteins in cell entryR35GM151169 · NIGMS · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI Maolin Lu · 2023 to 2026
$1.5M
Probing real-time conformational dynamics and allosteric cooperativity of the HIV-1 envelope glycoprotein during virus entryR01AI181600 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI Maolin Lu · 2024 to 2026
$1.3M
NIAID NIH HHS R01 AI145687NIAID NIH HHS R01 AI181600NIAID NIH HHS U54 AI170752NIGMS NIH HHS R35 GM151169
6 · The paper itself

Abstract

The hydrophobic fusion peptide (FP), a critical component of the HIV-1 entry machinery, is located at the N terminus of the envelope (Env) gp41 subunit. The receptor-binding gp120 subunit of Env forms a heterodimer with gp41. The gp120/gp41 heterodimer assembles into a homotrimer, in which FP is accessible for antibody binding. Env conformational changes or "opening" that follow receptor binding result in FP relocating to a newly formed interprotomer pocket at the gp41-gp120 interface where it is sterically inaccessible to antibodies. The mechanistic steps connecting the entry-related transition of antibody accessible-to-inaccessible FP configurations remain unresolved. Here, using SOSIP-stabilized Env ectodomains, we visualize that the FP remains accessible for antibody binding despite substantial receptor-induced Env opening. We delineate stepwise Env opening from its closed state to a functional CD4-bound symmetrically open Env in which we show that FP was accessible for antibody binding. We define downstream re-organizations that lead to the formation of a gp120/gp41 cavity into which the FP buries to become inaccessible for antibody binding. These findings improve our understanding of HIV-1 entry and delineate the entry-related conformational trajectory of a key site of HIV vulnerability to neutralizing antibody.

Indexed as

CD4 AntigensHIV-1HIV Envelope Protein gp120HIV Envelope Protein gp41HEK293 CellsHIV AntibodiesHumansProtein BindingProtein ConformationVirus InternalizationCD4 AntigensHIV AntibodiesHIV Envelope Protein gp120HIV Envelope Protein gp41

Identifiers

PMID40382314
PMCPMC12085566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.